DPL and collaborators to publish drug pricing primer series

Health Affairs, Drug Pricing Lab, Commonwealth Fund
July 24, 2017

The Drug Pricing Lab and Commonwealth Fund have partnered with Health Affairs to develop a 12-part series of educational primers on drug pricing issues in the United States. The comprehensive set of primers, along with three policy proposals for solutions to these issues, will be released in Health Affairs in fall 2017. The twelve primers of the series are available at the links below.

Expedited Approval Pathways

Pricing Orphan Drugs

Biosimilars

Patent Settlements

Medicare Part B

Medicare Part D

Medicaid Best Price

Veteran’s Health Administration

340B Drug Discount Program

Patient Financial Support

Formularies

Pharmacy Benefit Managers

Topics: